EUCTR2021-001655-13-NL进行中（未招募）1 期
SARS-CoV2 vaccination and activation of the coagulation system
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- Radboudumc
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- •- adult patients (age > 18 years)
- •- obtained written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •A potential subject who meets any of the following criteria will be excluded from participation in this study:
- •- patients with Down syndrome
- •- patients with known coagulation disorders
- •- patients on anticoagulants (vitamin K antagonist, low-molecular weight heparin or direct oral anticoagulants)
研究者
相似试验
已完成
4 期
SARS-CoV2 vaccination and activation of the coagulation systemcovid-19thrombosis1004743810014523NL-OMON51038Academisch Medisch Centrum40
暂停
不适用
Analysis of the effect of SARS-CoV-2 vaccination in patients with chronic inflammatory diseasesDRKS00024214KSH Kiel/1. medizinische Klinik/Rheumatologie100
招募中
不适用
SARS-CoV-2 (COVID-19) vaccination and the immune responses in patients with haematological malignancy and other immune deficiency.Haematological malignancyImmunosuppressionCOVID-19Blood - Haematological diseasesCancer - Leukaemia - Chronic leukaemiaCancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphomaCancer - Lymphoma (non Hodgkin's lymphoma) - Low grade lymphomaCancer - MyelomaInflammatory and Immune System - Other inflammatory or immune system disordersACTRN12622001509752The Perth Blood Institute450
进行中（未招募）
1 期
SARS-Cov-2 vaccine responsiveness in middle-aged and older personsSARS-CoV-19, frailtyEUCTR2021-001976-40-NLational Institute for Public Health and the Environment1,700
招募中
4 期
Monitoring immunogenicity of SARS-Cov-2 vaccination in Dutch middle-aged and older individuals (participating in the Doetinchem Cohort Study)NL-OMON54058Ministerie van Volksgezondheid, Welzijn en Sport (VWS)1,700